Clinical Trials
3 trialsNCT06841874 2025-12-24
Tale EAP
Nuvation Bio Inc.
No longer available
NCT04146571 2022-10-20
Expanded Access to Ensartinib for Participants With ALK+ NSCLC
Xcovery Holdings, Inc.
Available
NCT02784158 2018-02-06
An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer
Takeda
No longer available